Login
$NIKA
$0.41 -$0.01 (2.38%) Close

Insider Transactions

What Nika Pharmaceuticals Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 0 0
Total trades 0 0

Shares traded

3 months 12 months
Acquired 0 0
Disposed 0 0
Net activity +0 +0

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Savov Dimitar Slavchev CEO, CFO, President Mar 18 Open-market sale · S −2,000,000 $0.25 −$500K 455,589,500
Nika PHARMACEUTICALS, Inc President, CEO, CFO Jun 02 Open-market sale · S −3,500,000 $0.02 −$56K —
Nika PHARMACEUTICALS, Inc President, CEO, CFO Jan 31 Open-market sale · S −1,500,000 $0.01 −$15K —
Nika PHARMACEUTICALS, Inc President, CEO, CFO Jan 10 Open-market sale · S −6,300,000 $0.01 −$63K —
Nika PHARMACEUTICALS, Inc President, CEO, CFO Oct 24 Open-market sale · S −3,000,000 $0.04 −$111K —
Nika PHARMACEUTICALS, Inc President, CEO, CFO Sep 26 Open-market sale · S −1,250,000 $0.02 −$25K —
Nika PHARMACEUTICALS, Inc President, CEO, CFO Sep 12 Open-market sale · S −7,000,000 $0.02 −$140K —
Nika PHARMACEUTICALS, Inc Secretary Jul 20 Other Transaction · J +145,000,000 — — —
Nika PHARMACEUTICALS, Inc President, CEO, CFO Jul 20 Other Transaction · J +333,181,000 — — —
Nika PHARMACEUTICALS, Inc Secretary Apr 29 Other Transaction · J +5,000,000 $50,000.00 +$250B 5,000,000
Nika PHARMACEUTICALS, Inc President, CEO, CFO Apr 13 Open-market buy · P +11,489,000 $0.01 +$138K —
Nika PHARMACEUTICALS, Inc President, CEO, CFO Apr 13 Other Transaction · J +10,000,000 $3,000,000.00 +$30T 10,000,000

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support